Woodline Partners LP Immatics N.V. Transaction History

Woodline Partners LP

$13.5 Billion
Q4 2024

A detailed history of Woodline Partners LP transactions in Immatics N.V. stock. As of the latest transaction made, Woodline Partners LP holds 2,034,224 shares of IMTX stock, worth $9.19 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,034,224

Previous 2,501,962 18.69%

Holding current value

$9.19 Million

Previous $28.5 Million 49.34%

% of portfolio

0.11%

Previous 0.26%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$6.73 - $11.21 $3.15 Million - $5.24 Million	-467,738 Reduced 18.69%	2,034,224 $14.5 Million
Q3 2024 Nov 14, 2024	SELL	$10.93 - $12.92 $8.31 Million - $9.82 Million	-760,048 Reduced 23.3%	2,501,962 $28.5 Million
Q2 2024 Aug 14, 2024	BUY	$9.78 - $13.49 $8.68 Million - $12 Million	888,023 Added 37.41%	3,262,010 $37.9 Million
Q1 2024 May 15, 2024	BUY	$10.23 - $12.94 $3.11 Million - $3.93 Million	303,904 Added 14.68%	2,373,987 $25 Million
Q4 2023 Feb 14, 2024	SELL	$7.36 - $10.89 $2.43 Million - $3.59 Million	-329,917 Reduced 13.75%	2,070,083 $21.8 Million
Q3 2023 Nov 14, 2023	BUY	$11.01 - $12.62 $13.1 Million - $15 Million	1,186,116 Added 97.71%	2,400,000 $27.8 Million
Q2 2023 Aug 14, 2023	BUY	$5.92 - $12.72 $1.4 Million - $3 Million	235,922 Added 24.12%	1,213,884 $14 Million
Q1 2023 May 15, 2023	BUY	$6.74 - $9.44 $6.59 Million - $9.23 Million	977,962 New	977,962 $6.75 Million
Q2 2022 Aug 15, 2022	SELL	$6.0 - $9.37 $1.92 Million - $2.99 Million	-319,480 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.64 - $12.85 $2.82 Million - $5.45 Million	-424,010 Reduced 57.03%	319,480 $2.55 Million
Q4 2021 Feb 14, 2022	BUY	$10.81 - $14.38 $1.49 Million - $1.98 Million	137,570 Added 22.7%	743,490 $9.99 Million
Q3 2021 Nov 15, 2021	BUY	$11.58 - $15.46 $659,978 - $881,111	56,993 Added 10.38%	605,920 $7.88 Million
Q2 2021 Aug 16, 2021	SELL	$10.43 - $12.81 $529,072 - $649,800	-50,726 Reduced 8.46%	548,927 $6.37 Million
Q1 2021 May 17, 2021	BUY	$10.24 - $14.6 $905,185 - $1.29 Million	88,397 Added 17.29%	599,653 $6.72 Million
Q4 2020 Feb 16, 2021	BUY	$9.67 - $12.05 $3.14 Million - $3.91 Million	324,665 Added 174.0%	511,256 $5.52 Million
Q3 2020 Nov 16, 2020	BUY	$8.73 - $15.15 $1.63 Million - $2.83 Million	186,591 New	186,591 $1.98 Million

Others Institutions Holding IMTX

# of Institutions

Shares Held

92.5M

Call Options Held

313K

Put Options Held

377K

View Full List

About Immatics N.V.

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $345M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

More about IMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Immatics N.V. Transaction History